Dia.Pro launches four COVID-19 serology EIA kits

Share this

Launch Diagnostics Limited is pleased to announce that Dia.Pro Diagnostic Bioprobes srl, has developed and launched four new EIA microplate kits for the detection of novel Coronavirus COVID-19 antibodies in human serum and plasma.

Dia.Pro is a specialist Italian diagnostic company which develops, manufactures & markets a wide range of high-quality & trusted IVD’s for infectious disease diagnostics,

There are two kits for the detection of IgG or IgM to COVID-19 nucleocapsid and spike antigens, a kit for IgG to COVID-19 spike 1 and 2 and a fourth module-based immunoassay for the confirmation and typing of IgG antibodies to COVID-19 major-antigens.

These kits have been developed and evaluated in Northern Italy and are CE marked. The assays are intended to be used to show antibody response and immune status following COVID-19 infection.

Key Points

  • Four assays are currently available based on EIA, 96 well, microplate technology
  • The Dia.Pro COVID-19 assays can be run manually or automated on an ELISA processor
  • Method files are available for the Stratec Gemini, Dynex DS2 and Dynex DSX
  • The confirmation assay is a modular system to individually detect antibodies against COVID-19 Spike protein 1, Spike protein 2 and Nucleocapsid

Product Codes

Comments are closed.